Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q2 2024 Earnings

7MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.48

-0.4

-0.32

-0.24

Details

Expected EPS

-0.285714

Actual EPS

-0.24

Surprise EPS

0.05

Surprise Percent

+16%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.24 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.